Exact Mass: 433.3344

Exact Mass Matches: 433.3344

Found 63 metabolites which its exact mass value is equals to given mass value 433.3344, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glycolithocholate

2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]acetic acid

C26H43NO4 (433.3192)


Lithocholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conjugate. is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Lithocholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conjugate. is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Mofarotene

4-(2-{4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]phenoxy}ethyl)morpholine

C29H39NO2 (433.2981)


   

lipocarbazole A3

lipocarbazole A3

C30H43NO (433.3344)


   

spiropachysine-20-one

spiropachysine-20-one

C29H39NO2 (433.2981)


   

Gentamicin VII-3

Gentamicin VII-3

C19H39N5O6 (433.29)


   

ELAIDYLPHOSPHOCHOLINE

ELAIDYLPHOSPHOCHOLINE

C23H48NO4P (433.3321)


   

Glycolithocholic acid

Glycolithocholic acid

C26H43NO4 (433.3192)


CONFIDENCE standard compound; INTERNAL_ID 73

   

N-(3a-Hydroxy-5b-cholan-24-oyl)-glycine

N-(3a-Hydroxy-5b-cholan-24-oyl)-glycine

C26H43NO4 (433.3192)


BA-129-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C28H48FNO (433.372)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

C28H48FNO (433.372)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)N-(2-fluoro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C28H48NOF (433.372)


   

NAT 21:0

N-heneicosanoyl taurine

C23H47NO4S (433.3226)


   

stearic acid, compound with 2,2,2-nitrilotriethanol (1:1)

stearic acid, compound with 2,2,2-nitrilotriethanol (1:1)

C24H51NO5 (433.3767)


   
   

N,N,N-Trihexyl-1-hexanaminium bromide

N,N,N-Trihexyl-1-hexanaminium bromide

C24H52BrN (433.3283)


   

2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid

2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid

C26H43NO4 (433.3192)


   

(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oate

(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oate

C27H45O4- (433.3318)


Conjugate base of (25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oic acid.

   

4-[2-[4-[(Z)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine

4-[2-[4-[(Z)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine

C29H39NO2 (433.2981)


   

2-[2,4-bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]-N,N-diethylethanamine

2-[2,4-bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]-N,N-diethylethanamine

C28H37N2O2+ (433.2855)


   

3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]-4-(trimethylazaniumyl)butanoate

3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]-4-(trimethylazaniumyl)butanoate

C27H47NO3 (433.3556)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   
   

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]octadeca-9,12,15-trienamide

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]octadeca-9,12,15-trienamide

C27H47NO3 (433.3556)


   

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxynonan-2-yl)octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxynonan-2-yl)octadeca-6,9,12,15-tetraenamide

C27H47NO3 (433.3556)


   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyundecan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyundecan-2-yl)hexadeca-4,7,10,13-tetraenamide

C27H47NO3 (433.3556)


   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]hexadeca-7,10,13-trienamide

C27H47NO3 (433.3556)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-9-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-9-enamide

C27H47NO3 (433.3556)


   

(E)-2-(decanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

(E)-3-hydroxy-2-(undecanoylamino)undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(undecanoylamino)undec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

(E)-2-(dodecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

(E)-2-(dodecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

3,5-Di-tert-butyl-N,N-bis(tert-butyldimethylsilyl)aniline

3,5-Di-tert-butyl-N,N-bis(tert-butyldimethylsilyl)aniline

C26H51NSi2 (433.356)


   

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-4-hexenoate

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-4-hexenoate

C29H39NO2 (433.2981)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]dodec-5-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]dodec-5-enamide

C27H47NO3 (433.3556)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-8-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-8-enamide

C27H47NO3 (433.3556)


   

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C26H43NO4 (433.3192)


   

Glycolithocholate

N-[(3alpha,5beta)-3-hydroxy-24-oxocholan-24-yl]-glycine

C26H43NO4 (433.3192)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids The glycine conjugate of lithocholic acid.

   

N-heneicosanoyl taurine

N-heneicosanoyl taurine

C23H47NO4S (433.3226)


   

NA-Cit 18:4(6Z,9Z,12Z,15Z)

NA-Cit 18:4(6Z,9Z,12Z,15Z)

C24H39N3O4 (433.294)


   

NA-Dopamine 19:0

NA-Dopamine 19:0

C27H47NO3 (433.3556)


   

NA-His 19:1(9Z)

NA-His 19:1(9Z)

C25H43N3O3 (433.3304)


   

NA-Taurine 21:0

NA-Taurine 21:0

C23H47NO4S (433.3226)


   

NA-Thr 22:4(7Z,10Z,13Z,16Z)

NA-Thr 22:4(7Z,10Z,13Z,16Z)

C26H43NO4 (433.3192)


   
   
   

Cer 9:0;O2/18:4

Cer 9:0;O2/18:4

C27H47NO3 (433.3556)


   

ST 24:1;O2;Gly

ST 24:1;O2;Gly

C26H43NO4 (433.3192)


   

1-[(8z)-heptadec-8-en-1-yl]-2-methyl-9h-carbazol-3-ol

1-[(8z)-heptadec-8-en-1-yl]-2-methyl-9h-carbazol-3-ol

C30H43NO (433.3344)


   

1-(heptadec-8-en-1-yl)-2-methyl-9h-carbazol-3-ol

1-(heptadec-8-en-1-yl)-2-methyl-9h-carbazol-3-ol

C30H43NO (433.3344)


   

(3e,5e,7e,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,10-diol

(3e,5e,7e,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,10-diol

C29H39NO2 (433.2981)


   

10-hydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one

10-hydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one

C29H39NO2 (433.2981)